Pulmatrix, Inc.

Pulmatrix, Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. Pulmatrix, Inc. is not very popular among insiders. Pulmatrix, Inc. is a mediocre stock to choose.
Log in to see more information.
Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the discovery and develo...
PULM Fundamental Data by TradingView

News

Pulmatrix (NASDAQ:PULM) Coverage Initiated at StockNews.com
Pulmatrix (NASDAQ:PULM) Coverage Initiated at StockNews.com

Ticker Report Analysts at StockNews.com started coverage on shares of Pulmatrix (NASDAQ:PULM - Get Free Report) in a report released on Saturday. The brokerage set a "hold" rating on the biotechnology company's...\n more…

Pulmatrix (NASDAQ:PULM) Receives New Coverage from Analysts at StockNews.com
Pulmatrix (NASDAQ:PULM) Receives New Coverage from Analysts at StockNews.com

Ticker Report Stock analysts at StockNews.com started coverage on shares of Pulmatrix (NASDAQ:PULM - Get Free Report) in a research report issued on Friday. The firm set a "hold" rating on the biotechnology...\n more…

Pulmatrix (NASDAQ:PULM) Now Covered by Analysts at StockNews.com
Pulmatrix (NASDAQ:PULM) Now Covered by Analysts at StockNews.com

Ticker Report StockNews.com began coverage on shares of Pulmatrix (NASDAQ:PULM - Free Report) in a research note released on Thursday. The firm issued a hold rating on the biotechnology company's stock. Pulmatrix...\n more…

Pulmatrix Second Quarter 2024 Earnings: US$1.59 loss per share (vs US$1.05 loss in 2Q 2023)
Pulmatrix Second Quarter 2024 Earnings: US$1.59 loss per share (vs US$1.05 loss in 2Q 2023)

Simply Wall St Pulmatrix ( NASDAQ:PULM ) Second Quarter 2024 Results Key Financial Results Revenue: US$1.55m (down 16% from 2Q 2023...\n more…

Pulmatrix (NASDAQ:PULM) Research Coverage Started at StockNews.com
Pulmatrix (NASDAQ:PULM) Research Coverage Started at StockNews.com

Zolmax Equities researchers at StockNews.com began coverage on shares of Pulmatrix (NASDAQ:PULM - Get Free Report) in a report released on Wednesday. The brokerage set a "hold" rating on the biotechnology...\n more…

StockNews.com Initiates Coverage on Pulmatrix (NASDAQ:PULM)
StockNews.com Initiates Coverage on Pulmatrix (NASDAQ:PULM)

Ticker Report StockNews.com began coverage on shares of Pulmatrix (NASDAQ:PULM - Get Free Report) in a research note issued on Wednesday. The brokerage set a "hold" rating on the biotechnology company's stock...\n more…